S&P Dividend Aristocrats Target 25 Portfolio, 4th Quarter 2024 Series
Ticker Symbol: FGYSXX
25 Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
AOS |
A.O. Smith Corporation |
4% |
$86.45 |
AFL |
Aflac Incorporated |
4% |
112.47 |
ADM |
Archer-Daniels-Midland Company |
4% |
57.55 |
BF/B |
Brown-Forman Corporation |
4% |
46.60 |
CAT |
Caterpillar Inc. |
4% |
387.96 |
CVX |
Chevron Corporation |
4% |
148.75 |
CB |
Chubb Limited |
4% |
279.96 |
CINF |
Cincinnati Financial Corporation |
4% |
133.88 |
DOV |
Dover Corporation |
4% |
187.16 |
EXPD |
Expeditors International of Washington, Inc. |
4% |
121.41 |
XOM |
Exxon Mobil Corporation |
4% |
122.04 |
FAST |
Fastenal Company |
4% |
70.17 |
BEN |
Franklin Resources, Inc. |
4% |
19.35 |
GD |
General Dynamics Corporation |
4% |
296.90 |
GPC |
Genuine Parts Company |
4% |
133.67 |
HRL |
Hormel Foods Corporation |
4% |
31.07 |
JNJ |
Johnson & Johnson |
4% |
159.69 |
KMB |
Kimberly-Clark Corporation |
4% |
142.01 |
LIN |
Linde Plc |
4% |
469.44 |
NUE |
Nucor Corporation |
4% |
148.11 |
PG |
The Procter & Gamble Company |
4% |
168.16 |
TROW |
T. Rowe Price Group, Inc. |
4% |
106.60 |
TGT |
Target Corporation |
4% |
151.32 |
GWW |
W.W. Grainger, Inc. |
4% |
,1028.56 |
WST |
West Pharmaceutical Services, Inc. |
4% |
286.48 |
*As of the close of business on 10/8/24. Market values are for reference only and are not indicative of your
individual cost basis. Holdings were selected by applying each strategy as described in the prospectus.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Offering Date |
10/10/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
1/9/2026 |
Historical 12-Month Distribution Rate of Trust Holdings:* |
2.12% |
Historical 12-Month Distribution Per Unit:* |
$0.2116 |
Cash CUSIP |
30337N209 |
Reinvestment CUSIP |
30337N217 |
Fee Account Cash CUSIP |
30337N225 |
Fee Account Reinvestment CUSIP |
30337N233 |
*There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions
in the future. The historical 12-month distribution per unit and historical 12-month distribution rate of the
securities included in the trust are for illustrative purposes only and are not indicative of the trust’s distribution
or distribution rate. The historical 12-month distribution per unit is based on the weighted average of the
trailing 12-month distributions paid by the securities included in the portfolio. The historical 12-month
distribution rate is calculated by dividing the historical 12-month distributions by the trust’s offering price. The
historical 12-month distribution and rate are reduced to account for the effects of fees and expenses, which will
be incurred when investing in a trust. Certain of the issuers may have reduced their dividends or distributions
over the prior 12 months. The distribution per unit and rate paid by the trust may be higher or lower than the
amount shown above due to certain factors that may include, but are not limited to, a change in the dividends
or distributions paid by issuers, actual expenses incurred, or the sale of securities in the portfolio.
Fee Table (based on a $10 public offering
price per unit) |
|
Standard |
Fee/Wrap |
Deferred Sales Charge |
1.35% |
— |
Creation & Development Fee (C&D Fee) |
0.50% |
0.50% |
Maximum Sales Charge |
1.85% |
0.50% |
|
|
|
Estimated Organization Costs |
0.250% |
0.250% |
Estimated Annual Trust Operating Expenses |
0.185% |
0.185% |
The deferred sales charge will be deducted in three monthly installments commencing 1/17/25. When
the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the
price exceeds $10.00 per unit, you will pay an initial sales charge. The C&D fee is a charge of $0.050 per unit
collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee
will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%.
Estimated organization costs will be deducted from the assets of the trust at the end of the initial offering
period. Estimated organization costs and trust operating expenses are assessed on a fixed dollar amount per
unit basis which, as a percentage of average net assets, will vary over time. Actual expenses may be more or
less than the estimates. Please see “Fee Table” in the trust prospectus for additional information.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment
in this unmanaged unit investment trust
should be made with an understanding of
the risks involved with owning common
stocks, such as an economic recession and the
possible deterioration of either the financial
condition of the issuers of the equity
securities or the general condition of the
stock market.
You should be aware that the portfolio is concentrated in stocks in the industrials sector which involves additional risks, including limited diversification. The companies engaged in the industrials sector are subject to certain
risks, including a deterioration in the general state of the economy, intense competition, domestic and international politics, excess capacity and changing spending trends.
An investment in a portfolio containing mid-cap companies is subject to
additional risks, as the share prices of small-cap
companies and certain mid-cap
companies are often more volatile than those
of larger companies due to several factors,
including limited trading volumes, products,
financial resources, management inexperience
and less publicly available information.
Large capitalization companies may grow at a slower rate than the overall market.
Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.
As the use of Internet technology has
become more prevalent in the course of
business, the trust has become more
susceptible to potential operational risks
through breaches in cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.
The value of the securities held by the trust may be subject to
steep declines or increased volatility due to changes in
performance or perception of the issuers.
This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.
The S&P 500 Dividend Aristocrats Index is a product of S&P Dow Jones Indices LLC or its affiliates
("SPDJI") and has been licensed for use by First Trust Portfolios L.P. Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC ("S&P"); Dow Jones® is a
registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"); and these trademarks
have been licensed for use by SPDJI and sublicensed for certain purposes by First Trust Portfolios
L.P. The S&P Dividend Aristocrats Target 25 Portfolio is not sponsored, endorsed, sold or promoted
by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any
representation regarding the advisability of investing in such product nor do they have any liability
for any errors, omissions, or interruptions of the S&P 500 Dividend Aristocrats Index.